TIDMSCPA
RNS Number : 5459V
Scapa Group PLC
07 August 2020
7 August 2020
LEI No. 213800QIPVTK5ES5UU36
Scapa Group plc
('Scapa' or 'the Company')
Result of AGM
The Annual General Meeting for 2020 of Scapa Group plc (AIM:
SCPA) was held on Friday, 7 August 2020 at the offices of Scapa
Group plc, Manchester Road, Ashton-under-Lyne, Greater Manchester
OL7 0ED.
A poll was held on each of the resolutions proposed and each
resolution was passed. Resolutions 1 to 11 and 15 were passed as
ordinary resolutions and resolutions 12 to 14 were passed as
special resolutions.
Resolution For Against Withheld
=============================================== ============ =========== ===========
1 To receive the Annual Report and Accounts
of the Company for the financial year
ended 31 March 2020 102,477,067 0 2,000
100%* 0.00%*
============ =========== ===========
2 To approve the Directors' Remuneration
Report for the financial year ended 31
March 2020. 65,258,508 20,453,019 16,767,540
76.14%* 23.86%*
============ =========== ===========
3 To elect Chris Brinsmead as a Director 102,467,565 0 11,502
100%* 0.00%*
============ =========== ===========
4 To re-elect Heejae Chae as a Director 102,465,691 0 13,376
100%* 0.00%*
============ =========== ===========
5 To re-elect Oskar Zahn as a Director 102,464,591 1,100 13,376
99.99%* 0.01%*
============ =========== ===========
6 To re-elect David Blackwood as a Director 89,234,202 13,231,489 13,376
87.09%* 12.91%*
============ =========== ===========
7 To re-elect Brendan McAtamney as a
Director 90,195,650 12,270,041 13,376
88.03%* 11.97%*
============ =========== ===========
8 To elect Tim Miller as a Director 102,404,343 62,862 11,862
99.94%* 0.06%*
============ =========== ===========
9 To reappoint Deloitte LLP as auditor
of the Company 102,048,641 3,552 426,874
99.99%* 0.01%*
============ =========== ===========
10 To authorise the Directors to fix
the remuneration of the auditor 102,473,608 485 4,974
99.99%* 0.01%*
============ =========== ===========
11 To authorise the Directors to allot
shares 84,028,325 18,441,382 9,360
82.0%* 18.0%*
============ =========== ===========
12 To authorise the Directors to dis-apply
pre-emption rights in relation to the
customary 5% power pursuant to the statement
of principles dis-applying pre-emption
rights 82,996,946 19,472,761 9,360
81.0%* 19.0%*
============ =========== ===========
13 To authorise the Directors to dis-apply
pre-emption rights in relation to the
additional 5% power to be used in connection
with an acquisition or a specified capital
investment 80,543,615 21,915,490 19,962
78.61%* 21.39%*
============ =========== ===========
14 To authorise the Company to make market
purchases of its own shares 85,021,904 831,398 16,625,765
99.03%* 0.97%*
============ =========== ===========
15 To authorise the Company to make political
donations 100,031,652 2,383,541 63,874
97.67%* 2.33%*
============ =========== ===========
* as a percentage of votes cast
As announced on 23 June 2020, following this morning's AGM,
Larry Pentz has now stepped down as Chairman and is succeeded by
Chris Brinsmead who was appointed to the Board today. The Board
would like to extend its thanks to Larry for his guidance and
support and wish him well for the future.
The Board would like to thank its shareholders for their
engagement and support ahead of the AGM and throughout the year.
While all resolutions proposed at the AGM were passed with
significant majorities, the Board notes that Resolutions 2 and 13
were passed with more than 20% of votes cast against them. In
advance of the AGM, the Board developed a clear understanding of
the concerns raised by shareholders on each of these
resolutions.
In the period ahead, the Board, under the stewardship of its
newly appointed Chair, will continue to consult and engage with
shareholders in order to foster further understanding of their
expectations and views. The outcome of these engagements will be
detailed in next year's Annual Report and Accounts.
For further information:
Scapa Group plc:
Wendy Baker
Company Secretary +44 (0) 161 301 7400
Numis Securities Limited:
Mark Lander/Freddie Barnfield
(Joint Broker/Nominated Adviser) +44 (0) 20 7260 1000
About Scapa Group plc
Scapa Group plc is a diversified Healthcare and Industrial
company focused on bringing best-in-class innovation, design and
manufacturing solutions to its customers.
Healthcare
Scapa Healthcare is the trusted strategic partner of choice for
the world's leading companies in Advanced Wound Care, Consumer
Wellness and Medical Device Fixation. We partner with the top
global MedTech companies to develop and manufacture innovative skin
friendly medical device fixation and topical solutions, from
inception through to market delivery, from our state-of-the-art
facilities.
For further information, please visit
www.scapahealthcare.com
Industrial
Scapa Industrial is a global supplier of bonding solutions and
manufacturer of adhesive-based products which offer meaningful
value in industrial applications due to their lightweight,
easy-to-apply properties. We are recognised for our unparalleled
range of products, including adhesive tapes, films and foams, and
we can engineer custom designs for even the most unique
applications.
For further information, please visit
www.scapaindustrial.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
RAGUPUACRUPUGWM
(END) Dow Jones Newswires
August 07, 2020 09:46 ET (13:46 GMT)
Grafico Azioni Scapa (LSE:SCPA)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Scapa (LSE:SCPA)
Storico
Da Apr 2023 a Apr 2024
